Literature DB >> 33716453

Considerations When Managing Heart Failure during the COVID-19 Pandemic-Consensus from the Taiwan Society of Cardiology.

Kun-Chang Lin1, Chun-Chieh Wang2, Wei-Chun Huang1,3,4, Juey-Jen Hwang5,6.   

Abstract

Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since December 2019. Acute heart failure has accounted for 23-24% of the initial presentations in patients with COVID-19 infection. Furthermore, COVID-19 might increase metabolic demand and cause acute decompensation of pre-existing stable heart failure. These patients are thus more susceptible to the evolution of more serious clinical symptoms and a higher mortality rate. Given the lack of knowledge about this new disease, this review provides recommendations for the management of heart failure during the COVID-19 pandemic in Taiwan.

Entities:  

Keywords:  COVID-19; Heart failure; SARS-CoV-2

Year:  2021        PMID： 33716453      PMCID： PMC7953124          DOI： 10.6515/ACS.202103_37(2).20200916A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


  33 in total

1.  Coronavirus Disease 2019 (COVID-19) Information for Cardiologists　- Systematic Literature Review and Additional Analysis.

Authors:  Tadafumi Sugimoto; Atsushi Mizuno; Takuya Kishi; Naoya Ito; Chisa Matsumoto; Memori Fukuda; Nobuyuki Kagiyama; Tatsuhiro Shibata; Takashi Ohmori; Shogo Oishi; Jun Fuse; Keisuke Kida; Fujimi Kawai; Mari Ishida; Shoji Sanada; Issei Komuro; Koichi Node
Journal:  Circ J       Date:  2020-04-29       Impact factor: 2.993

Review 2.  Drug interactions and antiretroviral drug monitoring.

Authors:  Matthew Foy; C John Sperati; Gregory M Lucas; Michelle M Estrella
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

3.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  COVID-19 Illness and Heart Failure: A Missing Link?

Authors:  Mandeep R Mehra; Frank Ruschitzka
Journal:  JACC Heart Fail       Date:  2020-04-10       Impact factor: 12.035

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

9.  COVID-19 in patients with cardiovascular diseases.

Authors:  Jean-Sébastien Hulot
Journal:  Arch Cardiovasc Dis       Date:  2020-03-31       Impact factor: 2.340

Review 10.  Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19).

Authors:  Dave L Dixon; Benjamin W Van Tassell; Alessandra Vecchié; Aldo Bonaventura; Azita H Talasaz; Hessam Kakavand; Fabrizio DʼAscenzo; Antonio Perciaccante; Davide Castagno; Enrico Ammirati; Giuseppe Biondi-Zoccai; Michael P Stevens; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2020-05       Impact factor: 3.105
View more
  3 in total

1.  The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network.

Authors:  Martin R Cowie; Ricardo Mourilhe-Rocha; Hung-Yu Chang; Maurizio Volterrani; Ha Ngoc Ban; Denilson Campos de Albuquerque; Edward Chung; Cândida Fonseca; Yuri Lopatin; José Antonio Magaña Serrano; Lilyana Mircheva; Gustavo Adolfo Moncada-Paz; Zurab Pagava; Eugenio B Reyes; Clara Saldarriaga; Pedro Schwartzmann; David Sim Kheng Leng; Marcelo Trivi; Yoto Trifonov Yotov; Shelley Zieroth
Journal:  Int J Cardiol       Date:  2022-06-22       Impact factor: 4.039

2.  COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.

Authors:  Jen-Yu Hsu; Po-Yu Liu; Chien-Hao Tseng; Chia-Wei Liu; Wan-Ting Yang; Wei-Hsuan Huang; Shu-Yuan Li; Ya-Chun Liao; Ming-Ju Wu
Journal:  J Multidiscip Healthc       Date:  2021-10-27

Review 3.  Beta receptor blocker therapy for the elderly in the COVID-19 era.

Authors:  Elpidio Santillo; Monica Migale
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.